According to one forecast, the stem cell market will grow at an annual rate of 9.2% and attain a value of almost $16 billion by 2025. This prediction, from a 2017 study by Grand View Research, may not ...

As stem cell research continues to progress, the relatively new field of human induced pluripotent stem cells has emerged as a strong contender to provide needed therapies, without the ethical issues ...

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

Manufacturing is the key to the vast potential of stem cells. And the manufacturing operations of Orange County’s most prominent entry in the field are expected to remain here after its sale to a ...

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

Financial support and mentorship are crucial for encouraging women to consider STEM careers, bridging the gap in ...

Scientists are using artificial intelligence to ensure stem cells are good enough for patients, potentially breaking a bottleneck in making these regenerative medicines commercially available to ...

Today, Cellino Biotech, an autonomous cell therapy manufacturing company, announced an $80 million Series A financing round led by Leaps by Bayer along with 8VC, Humboldt Fund, and new investors ...